The petition opposed an FSSAI order in May 2023 that barred state officers from inspecting centrally licensed companies and centralised all businesses. Maharashtra FDA has moved the Bombay High Court against FSSAI's alleged parallel regulatory system. The petition challenges central control over inspections, licencing and enforcement under the.